PH
75
4
PFE
48
3
APH
80
5
BEN
45
4
VNO
54
3
TAP
43
2
FE
62
2
CAH
69
2
DHI
27
3
EXC
69
2
RHI
29
4
ISRG
71
4
ECL
54
4
SYY
48
4
NTAP
61
5
EQR
36
5
GME
97
3
DVN
29
2
COF
53
5
UAL
53
8
PH
75
4
PFE
48
3
APH
80
5
BEN
45
4
VNO
54
3
TAP
43
2
FE
62
2
CAH
69
2
DHI
27
3
EXC
69
2
RHI
29
4
ISRG
71
4
ECL
54
4
SYY
48
4
NTAP
61
5
EQR
36
5
GME
97
3
DVN
29
2
COF
53
5
UAL
53
8
Financhill
Back

Sage Therapeutics Stock Price Chart

Pacaso has reserved the Nasdaq ticker PCSO and is offering shares at just $2.80 - but only until May 29.

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.*Pacaso recently received their ticker reservation with Nasdaq
Sell
26

SAGE
Sage Therapeutics

Last Price:
$6.51
Seasonality Move:
-5.2%

7 Day Trial

ALL ACCESS PASS

$ 7

Could BOXABL Be the Tesla of Housing?

Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SAGE is experiencing selling pressure, which indicates risk of future bearish movement.

Sage Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 6.77 Sell
20-day SMA: 6.88 Sell
50-day SMA: 7.35 Sell
200-day SMA: 7.01 Sell
8-day EMA: 6.7 Sell
20-day EMA: 6.88 Sell
50-day EMA: 7.11 Sell
200-day EMA: 8.5 Sell

Sage Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.19 Sell
Relative Strength Index (14 RSI): 39.48 Sell
Chaikin Money Flow: -639538 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.6 - 7.5) Sell
Bollinger Bands (100): (6.54 - 7.82) Sell

Sage Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Sage Therapeutics Stock

Is Sage Therapeutics Stock a Buy?

  • Sage Therapeutics share price is 6.52 while SAGE 8-day simple moving average is 6.77, which is a Sell signal.
  • The stock price of SAGE is 6.52 while Sage Therapeutics 20-day SMA is 6.88, which makes it a Sell.
  • Sage Therapeutics 50-day simple moving average is 7.35 while SAGE share price is 6.52, making it a Sell technically.
  • SAGE stock price is 6.52 and Sage Therapeutics 200-day simple moving average is 7.01, creating a Sell signal.

SAGE Technical Analysis vs Fundamental Analysis

Sell
26
Sage Therapeutics (SAGE) is a Sell

Is Sage Therapeutics a Buy or a Sell?

  • Sage Therapeutics stock is rated a Sell
    The current Sage Therapeutics [SAGE] share price is $6.52. The Score for SAGE is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.

Sage Therapeutics Stock Info

Market Cap:
408.3M
Price in USD:
6.52
Share Volume:
806.7K

Sage Therapeutics 52-Week Range

52-Week High:
13.47
52-Week Low:
4.62
Sell
26
Sage Therapeutics (SAGE) is a Sell

Sage Therapeutics Share Price Forecast

Is Sage Therapeutics Stock a Buy?

  • Sage Therapeutics share price is 6.52 while SAGE 8-day exponential moving average is 6.70, which is a Sell signal.
  • The stock price of SAGE is 6.52 while Sage Therapeutics 20-day EMA is 6.88, which makes it a Sell.
  • Sage Therapeutics 50-day exponential moving average is 7.11 while SAGE share price is 6.52, making it a Sell technically.
  • SAGE stock price is 6.52 and Sage Therapeutics 200-day simple moving average is 8.50, creating a Sell signal.

Fundamental Analysis of Sage Therapeutics

Is Sage Therapeutics a good investment?

  • Analysts estimate an earnings increase this quarter of $0.69 per share, an increase next quarter of $0.42 per share, an increase this year of $2.76 per share, and an increase next year of $0.46 per share.

Technical Analysis of Sage Therapeutics

Should I short Sage Therapeutics stock?

* Sage Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.